In animal models of metabolic disease, there is incomplete recovery of insulin sensitivity after an antioxidant treatment [57] and only partial prevention of NAFLD progression in rats after N-acetylcysteine administration [114]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.